Juergen Richt

Dr. Juergen Richt, Ph.D., of Kansas State University College of Veterinary Medicine conducted independent clinical studies to verify the effectiveness of PenCheck, for Silver Lake Research Corporation in California.[1]For the study, Richt's team used climate data from the Midwest to recreate artificial stations in biosecurity chambers.[2]Richt and colleagues are focusing on compounds that can be administered orally or as a nasal spray.[3]Dr. Richt applauded scientists at Silver Lake Research Corporation for quickly developing a test that can deliver results in such a short period of time.[4]Dr Richt and his colleagues at Kansas State University are also focused on determining the appropriate combinations of ASFv proteins and how best to deliver them for a safe and effective vaccine.[5]

Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.

Mentions - Mentions are snippets of text that map to a person.

Docs - The number of documents that match to a person in Primer's corpus of news articles.

Full tech explainer here.

Create an article for Juergen Richt on Wikipedia

Remember to check the sources and follow Wikipedia's guidelines.


  • 4


  • 42


  • 25


Recent events

According to one study, coronavirus can survive on outdoor surfaces for longer in autumn

During the fall and in lower temperatures and humidity, the virus could, for example, remain in a person's clothes that constantly take to the streets for a week The authors of the scientific paper, Taeyong Kwon, Natasha N Gaudreault and Juergen A Richt, believe that "the virus would also survive longer indoors in colder and less humid conditions. Autumn in the United States could lead to potential COVID outbreaks.[2]


Event Date

How a K-State research lab is fighting back against COVID-19

Research at the Biosecurity Research Institute typically focuses on pathogens that threaten the food supply by infecting crops or livestock animals. With its complex ventilation system, multiple power backups, and highly trained staff, the Biosecurity Research Institute has been described as a “fortress for research.” These engineering features enable its researchers to safely handle dangerous animal and plant pathogens. The safeguards also allow Biosecurity Research Institute researchers to work with the novel coronavirus itself, a rarity in COVID-19 research.[3]


Event Date

Where are we with a vaccine for ASFv?

T-cells, specifically cytotoxic T lymphocytes, are key players in cellular immunity and are critical in defending against a viral challenge by recognising, attacking, and killing virally-infected cells. Possible future directions may include delivering these peptides in combination with other molecules that can boost the immune response to protect animals from disease. In the past, various research groups have used killed/inactivated ASFv as the immunogen, but this format did not protect animals from ASFv challenges.[5]


Event Date